FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/06/043194 [Registered on: 13/06/2022] Trial Registered Prospectively
Last Modified On: 08/06/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia
Dentistry 
Study Design  Other 
Public Title of Study   Comparison of intravenous clonidine vs tranexamic acid for intraoperative blood loss and quality of surgical field during orthognathic surgery 
Scientific Title of Study   Comparing the effectiveness of intravenous clonidine and tranexamic acid on intraoperative blood loss and quality of surgical field during orthognathic surgery-a randomised clinical trial 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Swetha Bhat 
Designation  Post graduate  
Affiliation  Saveetha Dental College and Hospital 
Address  Department of Oral and Maxillofacial Surgery, Saveetha Dental College and Hospital, Poonamallee High Road, Velappanchavadi, Chennai, Tamil Nadu
Department of Oral and Maxillofacial Surgery, Saveetha Dental College and Hospital, Poonamallee High Road, Velappanchavadi, Chennai, Tamil Nadu
Chennai
TAMIL NADU
600077
India 
Phone  7204078811  
Fax    
Email  swethavb95@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Prof Dr Senthilnathan Periasamy  
Designation  Proffessor  
Affiliation  Saveetha Dental College and Hospital 
Address  Department of Oral and Maxillofacial Surgery, Saveetha Dental College and Hospital, Poonamallee High Road, Velappanchavadi, Chennai, Tamil Nadu
Department of Oral and Maxillofacial Surgery, Saveetha Dental College and Hospital, Poonamallee High Road, Velappanchavadi, Chennai, Tamil Nadu
Chennai
TAMIL NADU
600077
India 
Phone  7204078811  
Fax    
Email  151904006.sdc@saveetha.com  
 
Details of Contact Person
Public Query
 
Name  Swetha Bhat 
Designation  Post graduate  
Affiliation  Saveetha Dental College and Hospital 
Address  Department of Oral and Maxillofacial Surgery, Saveetha Dental College and Hospital, Poonamallee High Road, Velappanchavadi, Chennai, Tamil Nadu
Department of Oral and Maxillofacial Surgery, Saveetha Dental College and Hospital, Poonamallee High Road, Velappanchavadi, Chennai, Tamil Nadu

TAMIL NADU
600077
India 
Phone  7204078811  
Fax    
Email  swethavb95@gmail.com  
 
Source of Monetary or Material Support  
Saveetha Dental College and Hospital, 162, Poonamallee high rd, Velappanchavadi, Chennai, Tamil Nadu 77 
Shapoorji PallonjiInfrastructure Capital Co Pvt Ltd, OM Nagar-2, panchavati society, Rabadia colony, Kodinar, Gujarat 362720 
 
Primary Sponsor  
Name  Saveetha Dental College and Hospital 
Address  Saveetha Dental College and Hospital, Poonamallee High Road, Velappanchavadi, Chennai, Tamil Nadu 600077  
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
Shapoorji PallonjiInfrastructure Capital Co Pvt Ltd  OM Nagar-2, Panchavati Society, Rabadia Colony, KOdinar-362720, Gir Somnath, Gujarat 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Swetha Bhat  Saveetha Dental College and Hospital  Department of Oral and Maxillofacial Surgery, Saveetha Dental College and Hospital, Poonamallee High Road, Velappanchavadi, Chennai, Tamil Nadu 600077 Chennai TAMIL NADU
Chennai
TAMIL NADU 
7204078811

swethavb95@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Instituitional Human Ethical Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: Q189||Congenital malformation of face and neck, unspecified, (2) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Intravenous Clonidine  Inj clonidine 3microgram/ kg To be administered half an hour before the start of the surgical procedure Total duration of the intervention- time from the beginning to the end of the surgical procedure  
Comparator Agent  Intravenous Tranexamic acid  Inj Tranexamic acid 20 mg/kg To be administered half an hour before the start of the surgical procedure Total duration of the intervention- time from the beginning to the end of the surgical procedure  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1) Patients of age 18-40years of age
2)Patients in American Society of Anaesthesiology
Classification I and II
3) Patient who were candidates for orthognathic
surgery 
 
ExclusionCriteria 
Details  1) History of systemic disease, coagulopathy,
bleeding disorder, vascular anomaly, recent
anticoagulant therapy.
2)Patients with bone disease (eg. Fibrous dysplasia)
3) Cleft lip and palate

4) Patients to receive simultaneous temporo-
mandibular joint surgery or bone graft harvest 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Intraoperative blood loss- At the end of the surgical procedure
Quality of surgical field-During the surgery
 
Primary outcome:
Intraoperative blood loss- at the end of the surgical procedure (Day of surgery)
Quality of surgical field- During the surgery (Day of surgery)
 
 
Secondary Outcome  
Outcome  TimePoints 
Drop in hemoglobin levels
Mean arterial pressure (MAP)
Operating time 
Drop in hemoglobin levels- After 24 hours
Mean arterial pressure- intraoperatively on the day of surgery
Operating time- By the end of the surgery (on day of surgery) 
 
Target Sample Size   Total Sample Size="32"
Sample Size from India="32" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   20/06/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - All of the individual participant data collected during the trial, after de-identification.

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan

  3. Who will be able to view these files?
    Response - Anyone

  4. For what types of analyses will this data be available?
    Response - Any purpose.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [swethavb95@gmail.com].

  6. For how long will this data be available start date provided 15-07-2022 and end date provided 15-07-2023?
    Response - Immediately following publication. No end date.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary  

Orthognathic surgery is a well-established method to correct various forms of dentofacial deformity. As
the orofacial region is very vascular, significant blood loss can occur and a subsequent need for blood
transfusion is often encountered. A surgical site with the least bloodshed possible contributes to
decreased surgical time, better visualization of the surgical field, and increased quality of the surgery.
Use of single intravenous preoperative dose of Tranexamic acid and Clonidine was effective in
preventing excessive postoperative bleeding. Better agent among these two drugs has not yet been
identified. This study aims to compare the efficacy of intranvenous clonidine and tranexamic acid as a
premedication to control intraoperative blood loss and producing a better surgical field during
orthognathic surgery

Sample size- 32

Groups: Group 1: 16 (Intravenous Clonidine)
Group 2: 16 (Intravenous Tranexamic acid)

Primary outcome:
1) Intraoperative blood loss
2) Quality of surgical field
Secondary outcomes:
1) Drop in hemoglobin levels
2) Mean arterial pressure (MAP)
3) Operating time
 
Close